Overview

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

Status:
Completed
Trial end date:
2010-12-20
Target enrollment:
Participant gender:
Summary
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered with a High Fat Meal or an Inhibitor of CYP2C8 (gemfibrozil),]
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Collaborator:
Octagon Research Solutions, Incoporated
Treatments:
Gemfibrozil
Glycine